ArticleBMC ophthalmology2026
Retinal and microvascular alterations in Alport syndrome: a multimodal imaging study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlport syndrome (AS) is a hereditary disorder caused by mutations in type IV collagen genes and is frequently associated with ocular manifestations. Although anterior segment findings are well described, retinal structural and microvascular alterations in AS remain insufficiently characterized. This study aimed to comprehensively characterize retinal structural and microvascular alterations in patients with AS using spectral-domain optical coherence tomography (SD-OCT) and swept-source OCT angiography (SS-OCTA).
methodsThis retrospective cross-sectional study included 68 eyes of 34 patients with genetically or clinically confirmed AS and 68 eyes of 68 age- and sex-matched healthy controls. Retinal layer thickness was measured at 500, 1000, 1500, and 3000 μm from the foveal center in the nasal and temporal quadrants using SD-OCT. SS-OCTA was used to quantify the foveal avascular zone (FAZ) area, acircularity index (AI), and vessel density (VD) in the superficial and deep capillary plexuses and flow/non-flow areas. All segmentations were manually reviewed and corrected accordingly. Intra-subject correlations were accounted for using generalized estimating equations with false discovery rate corrections for multiple comparisons.
resultsEyes with AS exhibited significant temporal macular thinning at all eccentricities (p < 0.001), predominantly involving the inner retinal layers but also affecting the outer plexiform and outer nuclear layers. The FAZ area was significantly smaller in the AS group than in the control group (0.19 ± 0.10 vs. 0.28 ± 0.10 mm²; p < 0.001), whereas the AI was higher (1.13 ± 0.07 vs. 1.10 ± 0.04; p = 0.025). VD was significantly reduced in both capillary plexuses, particularly in temporal and inferior quadrants (p < 0.001). Patients with foveal hypoplasia were excluded.
conclusionsAS is associated with temporal retinal thinning that extends from the inner to outer retinal layers, together with significant microvascular alterations predominantly in the temporal macula. These multimodal OCT and OCTA findings provide novel insights into the pathophysiology of the disease and highlight their potential as non-invasive biomarkers for the early detection and longitudinal monitoring of ocular involvement in AS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.